Beta-adrenergic blocking drugs in breast cancer: a perspective review
about
The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic ReviewAnalysis of the correlation among hypertension, the intake of β-blockers, and overall survival outcome in patients undergoing chemoradiotherapy with inoperable stage III non-small cell lung cancerCan analyses of electronic patient records be independently and externally validated? Study 2--the effect of β-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study.β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells.The β2-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion.Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.Biomarker identification in breast cancer: Beta-adrenergic receptor signaling and pathways to therapeutic response.The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatmentβ-adrenergic-blocking drugs and melanoma: current state of the art.Central and peripheral nervous systems: master controllers in cancer metastasis.The trophoblast model of cancer.The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference.Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies.Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma.Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database.Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch.Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process.β2ARs stimulation in osteoblasts promotes breast cancer cell adhesion to bone marrow endothelial cells in an IL-1β and selectin-dependent manner
P2860
Q28074666-D5A12807-DD5D-4226-B4FB-8C8B7251C909Q33622701-62C75158-BC6E-4C8B-B419-76832954D26FQ35466477-EE86CA38-1805-4C38-8513-C53D9972A2C0Q36213505-AC1DD3FC-732F-4EE8-8D47-DB1A0C4E82BDQ36570909-82520606-DADF-466E-AA1F-35AB07153472Q37465305-31696AAB-BE38-44DA-98DD-FAD11722F842Q37654991-2C794E43-D3F4-4E6E-9520-A4114BC35472Q37693485-02C635C5-8402-4464-8EFE-F6DF6457FC53Q38068208-9B64FD60-C8B9-4A27-AE72-E33325D99EBCQ38106901-965D767F-FF82-438D-A337-797078771D78Q38265246-0FAED3E4-1794-48F1-A952-9C0A8E86381FQ38664877-A8D5393D-672A-4B00-A31B-5F1D1C2ABE09Q42365355-ADA33615-6D91-4935-8176-3C3E06C1C169Q47101799-AC96F363-75BE-420C-B74B-6DD0F9D6F922Q47372688-0F144FE1-93EC-4E9F-8870-682C0B3D89C0Q47944205-9BAFAA63-59E1-4F25-A2D2-CE7AA6CBB89EQ48239000-E8B5FBA0-C7EF-4DA7-BFFF-B99CB1757B21Q58757708-9AC31141-604D-4087-8258-2E8A0FD4CB0E
P2860
Beta-adrenergic blocking drugs in breast cancer: a perspective review
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Beta-adrenergic blocking drugs in breast cancer: a perspective review
@ast
Beta-adrenergic blocking drugs in breast cancer: a perspective review
@en
type
label
Beta-adrenergic blocking drugs in breast cancer: a perspective review
@ast
Beta-adrenergic blocking drugs in breast cancer: a perspective review
@en
prefLabel
Beta-adrenergic blocking drugs in breast cancer: a perspective review
@ast
Beta-adrenergic blocking drugs in breast cancer: a perspective review
@en
P2093
P2860
P356
P1476
Beta-adrenergic blocking drugs in breast cancer: a perspective review
@en
P2093
Kala Visvanathan
Linda Sharp
Thomas I Barron
P2860
P304
P356
10.1177/1758834012439738
P577
2012-05-01T00:00:00Z